Sermorelin Acetate

Price range: $32.00 through $73.00

+ $9.99 Shipping · 7-day returns
Product specifications
  • Product: Sermorelin Acetate
  • Analysis: Read the applicable published COA for its methods, results and reporting limits.
  • Class: Growth Hormone-Releasing Hormone (GHRH) Fragment
  • Form: Lyophilized powder
  • CAS: 86168-78-7
  • Molecular Weight: 3357.93 g/mol
  • Storage: Store at -20°C (long term). Refrigerate after reconstitution.
  • Use: For in-vitro research use only. Not for human consumption.

Research Use Only. Not for Human Consumption.

SKU: SMO-VAR Category: Tags: GH research, GHRH, GHRH 1-29, growth hormone releasing hormone, pituitary, sermorelin
Secure checkout — Visa, Mastercard, Amex, Discover & Apple Pay

This listing is for Sermorelin Acetate in lyophilized powder form. Its vial options belong to the same standalone product, so the comparison below keeps the material identity separate from the amount you select.

Configuration & published evidence

Compare Sermorelin vial options

Keep the acetate identity on your purchasing record and use the selected vial amount when matching a published report. Price per labeled milligram helps compare the available sizes.

Available configurations, prices and associated published analysis records
ConfigurationPricePublished COA
2mg $32.00$16.00/mg labeled View record
5mg $45.00$9.00/mg labeled View record
10mg $73.00$7.30/mg labeled View record

Unit prices use the listed amount or volume, not measured purity or a dosing quantity. Confirm the selected price above. Each report identifies its own issuer, configuration, lot and methods; its publication does not identify the lot currently shipping.

Verified Purity
HPLC + Mass Spec Tested
Secure SSL Checkout

Batch documentation

Certificate of analysis

COA library

Apex Laboratory results for the listed configurations. Match the lot on your label with the report.

Sermorelin Acetate - 10 mg

Lot
APX-2026-0701-S
COA issued
Jul 1, 2026
Issuing laboratory
Apex Laboratory
Sermorelin Acetate chromatographic purity
99.894 % integrated detector area
Sermorelin Acetate active content
10 mg/vial
GHRHR cAMP response relative potency
100.05 % reference response potency
Bacterial endotoxins
<0.025 EU/mg active-equivalent

Chromatographic purity by analyte

Chromatographic purity by analyte for Sermorelin Acetate - 10 mg, lot APX-2026-0701-S. Recorded scalar results against the stated specification. Each row uses its own labeled scale; purity is detector-area purity, not active-material content.
About this graph

Recorded scalar results against the stated specification. Each row uses its own labeled scale; purity is detector-area purity, not active-material content.

Enlarge graph: Chromatographic purity by analyte (opens in a new tab)

Measured active content

Measured active content for Sermorelin Acetate - 10 mg, lot APX-2026-0701-S. Calibrated active content, concentration or activity compared with the stated same-unit specification. Each row uses its own labeled scale; no conversion from chromatographic purity is made.
About this graph

Calibrated active content, concentration or activity compared with the stated same-unit specification. Each row uses its own labeled scale; no conversion from chromatographic purity is made.

Enlarge graph: Measured active content (opens in a new tab)

Sermorelin Acetate - 5 mg

Lot
APX-2026-0630-S
COA issued
Jun 30, 2026
Issuing laboratory
Apex Laboratory
Sermorelin Acetate chromatographic purity
99.955 % integrated detector area
Sermorelin Acetate active content
5.00595 mg/vial
GHRHR cAMP response relative potency
100.05 % reference response potency
Bacterial endotoxins
<0.025 EU/mg active-equivalent

Chromatographic purity by analyte

Chromatographic purity by analyte for Sermorelin Acetate - 5 mg, lot APX-2026-0630-S. Recorded scalar results against the stated specification. Each row uses its own labeled scale; purity is detector-area purity, not active-material content.
About this graph

Recorded scalar results against the stated specification. Each row uses its own labeled scale; purity is detector-area purity, not active-material content.

Enlarge graph: Chromatographic purity by analyte (opens in a new tab)

Measured active content

Measured active content for Sermorelin Acetate - 5 mg, lot APX-2026-0630-S. Calibrated active content, concentration or activity compared with the stated same-unit specification. Each row uses its own labeled scale; no conversion from chromatographic purity is made.
About this graph

Calibrated active content, concentration or activity compared with the stated same-unit specification. Each row uses its own labeled scale; no conversion from chromatographic purity is made.

Enlarge graph: Measured active content (opens in a new tab)

Sermorelin Acetate - 2 mg

Lot
APX-2026-0628-S
COA issued
Jun 28, 2026
Issuing laboratory
Apex Laboratory
Sermorelin Acetate chromatographic purity
99.874 % integrated detector area
Sermorelin Acetate active content
1.99974 mg/vial
GHRHR cAMP response relative potency
100.05 % reference response potency
Bacterial endotoxins
<0.025 EU/mg active-equivalent

Chromatographic purity by analyte

Chromatographic purity by analyte for Sermorelin Acetate - 2 mg, lot APX-2026-0628-S. Recorded scalar results against the stated specification. Each row uses its own labeled scale; purity is detector-area purity, not active-material content.
About this graph

Recorded scalar results against the stated specification. Each row uses its own labeled scale; purity is detector-area purity, not active-material content.

Enlarge graph: Chromatographic purity by analyte (opens in a new tab)

Measured active content

Measured active content for Sermorelin Acetate - 2 mg, lot APX-2026-0628-S. Calibrated active content, concentration or activity compared with the stated same-unit specification. Each row uses its own labeled scale; no conversion from chromatographic purity is made.
About this graph

Calibrated active content, concentration or activity compared with the stated same-unit specification. Each row uses its own labeled scale; no conversion from chromatographic purity is made.

Enlarge graph: Measured active content (opens in a new tab)

Sermorelin Acetate is the acetate salt of GHRH(1-29)-NH₂, the truncated 29-residue N-terminal fragment of human growth hormone-releasing hormone. The latest published in-house report is Sermorelin Acetate – 10 mg — lot APX-2026-0701-S (COA issued 2026-07-01). Match the report configuration and lot to the label on your material. Supplied by Apex Laboratory as a high-purity reagent for in-vitro laboratory research and development use only; not for human consumption, veterinary use, or any therapeutic application.

Compound Overview

Sermorelin reproduces the minimal sequence required for full agonist activity at the growth hormone-releasing hormone receptor (GHRHR), a class B (secretin-family) G-protein-coupled receptor expressed on anterior pituitary somatotrophs. Native GHRH is a 44-amino-acid peptide, but pharmacology studies established decades ago that biological potency resides almost entirely in the first 29 residues; sermorelin is therefore that fragment, capped with a C-terminal amide to slow exopeptidase cleavage. Receptor engagement couples through Gαs, raising intracellular cAMP and triggering pulsatile synthesis and release of endogenous growth hormone rather than substituting for it.

This receptor-level mechanism is what distinguishes sermorelin from its siblings in the growth-hormone-axis toolkit. Unlike the growth hormone secretagogues that act on the ghrelin receptor (GHS-R1a) — ipamorelin and the GHRP series — sermorelin works exclusively on the GHRHR arm. Compared with CJC-1295, which is a tetra-substituted GHRH(1-29) analog engineered for protease resistance, sermorelin is the unmodified parent fragment, giving it a short, native-like profile that makes it a clean reference point for receptor-binding and signaling work. It also sits one structural step below tesamorelin, a stabilized full-length GHRH(1-44) analog, allowing side-by-side comparison of fragment versus full-length GHRH constructs at the same receptor.

Research Background & Published Literature

Sermorelin is one of the most thoroughly characterized GHRH analogs in the endocrinology literature. Marketed historically under the brand name Geref, it was applied as a diagnostic probe for evaluating anterior pituitary somatotroph reserve, and that legacy generated an extensive body of pharmacology describing GHRHR binding affinity, cAMP signaling kinetics, and the pulsatile dynamics of GH secretion in model systems. Apex supplies research-grade material only; the historical clinical use is provided for scientific context and does not constitute any approval of this reagent for human application. Within the laboratory, sermorelin remains a benchmark agonist for probing the secretin-family receptor class and for dissecting the somatotroph signaling cascade.

Researchers reviewing the published record on this fragment can use the following peer-reviewed and database resources for additional context on its receptor mechanism, signaling pathways, and experimental use in controlled laboratory settings:

Technical Specifications

Product Name Sermorelin Acetate
Other Names / Synonyms GHRH(1-29)-NH₂ · GRF(1-29) · Geref (historical brand)
Classification Growth hormone-releasing hormone (GHRH) fragment / GHRHR agonist
CAS Number 86168-78-7
Molecular Formula C₁₄₉H₂₄₆N₄₄O₄₂S
Molecular Weight 3357.93 g/mol (batch [M+H]⁺ found 3358.17 vs expected 3357.88)
Sequence / Structure 29-residue N-terminal fragment of GHRH(1-44), C-terminal amide
Purity Specification ≥99% (HPLC + MS verified — this lot 99.42%, see chromatogram above)
Physical Form Lyophilized (freeze-dried) powder · sealed glass vial
Recommended Diluent Bacteriostatic water or sterile laboratory-grade water
Available Sizes 2 mg · 5 mg · 10 mg
Intended Use In-vitro research only — not for human consumption

Storage, Handling & Stability

As an unmodified native-sequence fragment, sermorelin lacks the fatty-acid or substitution-based protection built into longer-acting analogs, so it is comparatively sensitive to handling and benefits from disciplined cold-chain practice. Store the lyophilized vial at -20°C for long-term stability, where the dry powder is robust for extended periods. Once reconstituted with a sterile diluent, hold working solution at 2–8°C, use it promptly, and divide it into single-use aliquots so the bulk stock is not subjected to repeated freeze-thaw stress. The peptide reconstitution calculator will convert your vial mass and chosen solvent volume into a precise mg/mL working concentration.

  • Keep the powder dry and sealed; resuspend only the portion needed for the immediate experiment.
  • Limit ambient-temperature exposure during weighing and dilution to preserve the amide-capped C-terminus.
  • Avoid aggressive vortexing of the reconstituted solution; swirl gently to dissolve the lyophilizate.
  • Label every aliquot with compound name, concentration, reconstitution date, and operator initials for full lot traceability.
  • Wear appropriate PPE and follow your institution’s chemical safety protocols at all times.

Quality Assurance & Analytical Verification

Every sermorelin lot passes a dual-verification release protocol before it is added to inventory: reversed-phase High-Performance Liquid Chromatography to quantify chromatographic purity, and Mass Spectrometry to confirm molecular identity against the expected 3357.88 Da monoisotopic-corrected mass. See Sermorelin Acetate – 10 mg — lot APX-2026-0701-S, issued 2026-07-01, for the recorded results, acceptance criteria and methods.

At roughly 3,358 Da, sermorelin is large enough that electrospray ionization (ESI+) typically resolves it across several charge states — the doubly and triply protonated ions are used to back-calculate a single consistent parent mass, a more rigorous identity check than relying on one signal alone. For a walkthrough of how this confirmation is performed, see our guide to mass spectrometry for peptide verification, or review how to interpret each field on the document in how to read a Certificate of Analysis. Current and historical batch reports are archived in the Lab Verified collection.

Frequently Asked Questions

What makes sermorelin different from CJC-1295 or tesamorelin?

All three act on the GHRH receptor, but they differ structurally. Sermorelin is the unmodified GHRH(1-29) fragment with a native sequence and a short, native-like profile. CJC-1295 is the same 29-residue backbone with four amino-acid substitutions engineered for protease resistance, while tesamorelin is a stabilized full-length GHRH(1-44) analog. That makes sermorelin a useful unmodified reference compound when researchers want to isolate the effect of those engineering modifications in receptor-binding and signaling assays.

Why does sermorelin act on a different receptor than ipamorelin or the GHRP peptides?

Sermorelin is a GHRH-receptor (GHRHR) agonist. The growth hormone secretagogues — ipamorelin, GHRP-2, and GHRP-6 — instead bind the ghrelin receptor GHS-R1a. The two receptor systems regulate somatotroph activity through distinct signaling arms, which is why GHRH analogs and secretagogues are frequently studied as complementary, mechanistically separate models in growth-hormone-axis research.

What diluent and concentration should be used to reconstitute this fragment?

Bacteriostatic water or sterile laboratory-grade water is the standard diluent for lyophilized GHRH fragments. The exact volume depends on the working concentration your protocol requires; the reconstitution calculator derives mg/mL and mcg/mL from the vial mass and solvent volume. Because sermorelin is an unmodified fragment, prepare only what you need and keep reconstituted solution cold.

What does the 99.42% purity figure on the COA mean for my experiments?

HPLC area purity describes the integrated detector response assigned to the target peak; it is distinct from net peptide content or measured mass per vial. See Sermorelin Acetate – 10 mg — lot APX-2026-0701-S, issued 2026-07-01, for the recorded results, acceptance criteria and methods. A high, documented purity reduces the chance that signaling artifacts in receptor or cell-based assays arise from synthesis-related impurities rather than the compound itself — see why ≥99% purity matters for the experimental rationale.

Is this product approved for human use?

No. All compounds sold by Apex Laboratory are classified as chemical research reagents intended strictly for in-vitro laboratory research. They are not approved for human consumption, veterinary use, or any therapeutic application. The historical clinical product Geref is referenced only for scientific context; this research-grade sermorelin acetate is not a substitute for it and carries no human-use authorization. Purchasers who imply intended bodily use will have their orders cancelled and their accounts permanently suspended.

Related Research Compounds

Researchers studying the GHRH-receptor arm of the growth-hormone axis may also be interested in related reagents from Apex Laboratory: CJC-1295 No DAC (substituted GHRH(1-29) analog), Tesamorelin (stabilized GHRH(1-44) analog), and Ipamorelin (selective GHS-R1a secretagogue) for cross-receptor comparison. Browse the full Apex Laboratory research catalog to see the complete range of peptides and reagents.

Shipping, Packaging & Delivery

Orders confirmed before 2:00 PM Eastern Time on a business day are dispatched the same day through tracked US domestic carriers. Each sermorelin vial travels in insulated, temperature-appropriate packaging chosen to protect the lyophilized peptide in transit. Move the vial to -20°C storage as soon as it arrives. If your protocol is time-critical or you need a specific delivery window, reach out ahead of ordering and our team will help schedule the shipment around your laboratory’s workflow.

Research Use Disclaimer

For in-vitro research use only. Not for human consumption. All products sold by Apex Laboratory — including Sermorelin Acetate — are intended exclusively for qualified researchers, accredited laboratories, and educational institutions. This material is supplied as a chemical research reagent and is not approved for any human or veterinary therapeutic use. Purchasers assume full responsibility for safe handling, proper storage, and compliance with all applicable federal, state, and local laws, regulations, and institutional policies governing the purchase and use of chemical research reagents.

Vial size

2mg, 5mg, 10mg

Latest published COA configuration Sermorelin Acetate - 10 mg
Latest published COA lot APX-2026-0701-S
COA issue date 2026-07-01
Issuing laboratory Apex Laboratory
COA approved by K. Norwood